Bioventus, Inc. (BVS)
8.51
-0.36
(-4.06%)
USD |
NASDAQ |
May 29, 16:00
8.60
+0.09
(+1.06%)
After-Hours: 07:47
Bioventus EPS Diluted (Quarterly) : 0.0445 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Axogen, Inc. | -0.3796 |
| Accuray, Inc. | -0.095 |
| Masimo Corp. | 1.070 |
| ResMed, Inc. | 2.736 |
| Rockwell Medical, Inc. | -0.0407 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.946M |
| Revenue (Quarterly) | 132.09M |
| Total Expenses (Quarterly) | 128.98M |
| Enterprise Value | 874.47M |
| Gross Profit Margin (Quarterly) | 67.88% |
| Profit Margin (Quarterly) | 2.99% |
| Earnings Yield | 4.84% |
| Operating Earnings Yield | 10.42% |
| Normalized Earnings Yield | 5.322 |